1.
Rev Infirm
; 72(294): 42-44, 2023 Oct.
Artigo
em Francês
| MEDLINE
| ID: mdl-37838372
RESUMO
CAR-T cell therapy for patients with hematological malignancies has been practiced at the Basse-Normandie Hematology Institute since November 2022. This treatment requires the care pathway to be coordinated by the nurse coordinator. Nurses play a key role in the early diagnosis of side effects induced by this drug. Interdisciplinary collaboration and the value of teamwork are also emphasized.